The future of sarcoma treatment

Area of Science:

• Oncology
• Orthopedic Surgery
• Multidisciplinary Care

Background:

• Osteogenic sarcoma management has seen significant advancements over the past two decades.
• Progress in soft tissue sarcoma treatment has lagged considerably behind osteogenic sarcoma.
• Osteogenic sarcoma treatment exemplifies successful multidisciplinary collaboration.

Purpose of the Study:

• To highlight the contrast in management progress between osteogenic and soft tissue sarcomas.
• To identify factors contributing to the lagging progress in soft tissue sarcoma care.
• To propose a model for improving soft tissue sarcoma treatment outcomes.

Main Methods:

• Comparative analysis of treatment management strategies for osteogenic and soft tissue sarcomas.
• Review of existing literature on sarcoma care collaboration and fragmentation.
• Identification of key specialists involved in the care of both sarcoma types.

Main Results:

• Osteogenic sarcoma treatment involves coordinated efforts of orthopedic surgeons, medical oncologists, and pediatric oncologists, leading to improved survival and limb salvage.
• Soft tissue sarcoma care is fragmented across numerous specialties, including medical, pediatric, and radiation oncologists, and various surgical specialists.
• Treatment for soft tissue sarcomas often occurs before referral to specialized centers, leading to management variations.

Conclusions:

• Centralizing soft tissue sarcoma care within referral centers is crucial for improving patient outcomes.
• Standardized cooperative protocols are needed for effective soft tissue sarcoma management.
• Adoption of a multidisciplinary, collaborative approach similar to osteogenic sarcoma treatment is essential for advancing soft tissue sarcoma care.